Literature DB >> 271040

Carcinocythemia (carcinoma cell leukemia) due to metastatic carcinoma of the breast: report of a case.

R L Myerowitz, P A Edwards, G P Sartiano.   

Abstract

A patient with a 17-year course of metastatic lobular carcinoma of the breast is described who developed large numbers of circulating carcinoma cells which were easily detectable in several routine peripheral blood smears shortly before death. This rare complication of carcinoma has been called "carcinocythemia." Carcinocythemia is probably due to widespread infiltration of many bone marrow sites and may also be related to splenectomy, which may impair reticuloendothelial clearance of circulating tumor cells. The differential diagnosis of carcinocythemia from superimposed acute myelogenous leukemia, which can complicate radiotherapy and chemotherapy for the primary tumor, is discussed. Cytomorphology, histochemistry, and electron microscopy of abnormal circulating cells should aid in the distinction of these two processes.

Entities:  

Mesh:

Year:  1977        PMID: 271040     DOI: 10.1002/1097-0142(197712)40:6<3107::aid-cncr2820400653>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Carcinocythemia. A terminal manifestation of metastatic breast cancer.

Authors:  D M Aboulafia
Journal:  West J Med       Date:  1992-12

2.  Carcinocythemia due to metastatic oat-cell carcinoma of the lung.

Authors:  G C Ejeckam; S K Sogbein; W A McLeish
Journal:  Can Med Assoc J       Date:  1979-02-03       Impact factor: 8.262

Review 3.  Circulating tumor cell enrichment based on physical properties.

Authors:  Ramdane A Harouaka; Merisa Nisic; Si-Yang Zheng
Journal:  J Lab Autom       Date:  2013-07-05

4.  Liquid Biopsy in Breast Cancer: Circulating Tumor Cells and Circulating Tumor DNA.

Authors:  Tae-Kyung Yoo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.

Authors:  Minetta C Liu; Peter G Shields; Robert D Warren; Philip Cohen; Mary Wilkinson; Yvonne L Ottaviano; Suman B Rao; Jennifer Eng-Wong; Francoise Seillier-Moiseiwitsch; Anne-Michelle Noone; Claudine Isaacs
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

6.  Breast cancer with an unusual leukemia-like presentation: case report and literature review.

Authors:  Yuan-Hsin Chang; Ruey-Kuen Hsieh; Ming-Chi Chang; Gon-Shen Chen
Journal:  Med Oncol       Date:  2007-07-28       Impact factor: 3.064

Review 7.  Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.

Authors:  Ramdane Harouaka; Zhigang Kang; Si-Yang Zheng; Liang Cao
Journal:  Pharmacol Ther       Date:  2013-10-14       Impact factor: 12.310

8.  Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.

Authors:  Sjoerd T Ligthart; Frank A W Coumans; Francois-Clement Bidard; Lieke H J Simkens; Cornelis J A Punt; Marco R de Groot; Gerhardt Attard; Johann S de Bono; Jean-Yves Pierga; Leon W M M Terstappen
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

9.  Primary colonic signet ring cell carcinoma presenting carcinocythemia: an autopsy case.

Authors:  Ryosuke Misawa; Motohiro Kobayashi; Makoto Ito; Mai Kato; Yuji Uchikawa; Satoshi Takagi
Journal:  Case Rep Gastroenterol       Date:  2008-09-30

10.  Metastasis and Circulating Tumor Cells.

Authors:  Guus van Dalum; Linda Holland; Leon Wmm Terstappen
Journal:  EJIFCC       Date:  2012-10-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.